BTN3A1 and systemic lupus erythematosus: However, our study showed that a 50 μg/kg IL‐38 dose was more effective than 100 μg/kg in reducing BTN3A1‐induced inflammation and lupus‐like phenotype, although both reversed the inflammatory responses and renal damages (higher doses were only significantly effective in some indicators).